✦ LIBER ✦

The Comparative Safety of Various Intravenous Iron Preparations in Chronic Kidney Disease Patients

✍ Scribed by Anirban, Ganguli; Kohli, H.S.; Jha, Vivekanand; Gupta, K.L.; Sakhuja, Vinay

Book ID: 120971999
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 163 KB
Volume: 30
Category: Article
ISSN: 0886-022X
DOI: 10.1080/08860220802134631

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ferumoxytol: A New Intravenous Iron Prep

Ferumoxytol: A New Intravenous Iron Preparation for the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease

✍ Michael H. Schwenk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Intravenous iron treatment in paediatric

Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin

✍ Henry E. G. Morgan; Richard C. L. Holt; Caroline A. Jones; Brian A. Judd 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 74 KB

TOTAL DOSE INFUSION OF INTRAVENOUS IRON

TOTAL DOSE INFUSION OF INTRAVENOUS IRON IN PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HAEMODIALYSIS

✍ Sean Fenwick; George Peebles 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 580 KB

Intravenous Iron Therapy and Risk for Pr

Intravenous Iron Therapy and Risk for Progressive Loss of Kidney Function in Patients with Chronic Kidney Disease

✍ Mansour, Wissam; Bissram, Melisha; Rosner, Mitchell H. 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 140 KB

Iron deficiency in patients with chronic

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

✍ James B. Post; Barry M. Wilkes; Michael F. Michelis 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 157 KB

FDA report: Ferumoxytol for intravenous

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Feraheme™ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise